The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chirmule, N.
Right arrow Articles by Serfling, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chirmule, N.
Right arrow Articles by Serfling, E.
The Journal of Immunology, 1999, 163: 644-649.
Copyright © 1999 by The American Association of Immunologists

CD4-Mediated Signals Induce T Cell Dysfunction In Vivo1

Narendra Chirmule2,*, Andris Avots{ddagger}, S. M. Lakshmi Tamma{dagger}, Savita Pahwa{dagger} and Edgar Serfling{ddagger}

* Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia, PA, 19104; {dagger} Department of Pediatrics, North Shore University Hospital-New York University School of Medicine, Manhasset, NY 11030; and {ddagger} Department of Molecular Pathology, Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany

Triggering of CD4 coreceptors on both human and murine T cells can suppress TCR/CD3-induced secretion of IL-2. We show here that pretreatment of murine CD4+ T cells with the CD4-specific mAb YTS177 inhibits the CD3-mediated activation of the IL-2 promoter factors NF-AT and AP-1. Ligation of CD4 molecules on T cells leads to a transient stimulation of extracellular signal-regulated kinase (Erk) 2, but not c-Jun N-terminal kinase (JNK) activity. Pretreatment with anti-CD4 mAb impaired anti-CD3-induced Erk2 activation. Costimulation with anti-CD28 overcame the inhibitory effect of anti-CD4 Abs, by induction of JNK activation. The in vivo relevance of these studies was demonstrated by the observation that CD4+ T cells from BALB/c mice injected with nondepleting anti-CD4 mAb were inhibited in their ability to respond to OVA Ag-induced proliferation and IL-2 secretion. Interestingly, in vivo stimulation with anti-CD28 mAb restored IL-2 secretion. Furthermore, animals pretreated with anti-CD4 elicited enhanced IL-4 secretion induced by OVA and CD28. These observations suggest that CD4-specific Abs can inhibit T cell activation by interfering with signal 1 transduced through the TCR, but potentiate those delivered through the costimulatory molecule CD28. These studies have relevance to understanding the mechanism of tolerance induced by nondepleting anti-CD4 mAb used in animal models for allograft studies, autoimmune pathologies, and for immunosuppressive therapies in humans.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. A. Rider, C. E.G. Havenith, R. de Ridder, J. Schuurman, C. Favre, J. C. Cooper, S. Walker, O. Baadsgaard, S. Marschner, J. G.J. vandeWinkel, et al.
A Human CD4 Monoclonal Antibody for the Treatment of T-Cell Lymphoma Combines Inhibition of T-Cell Signaling by a Dual Mechanism with Potent Fc-Dependent Effector Activity
Cancer Res., October 15, 2007; 67(20): 9945 - 9953.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Tatari-Calderone, J. L. Brogdon, K. W. Tinsley, A. Ramezani, and D. Leitenberg
CD4-Dependent Signaling Is Required for a Late Checkpoint during Th2 Development Associated with Resistance to Activation-Induced Cell Death
J. Immunol., November 1, 2005; 175(9): 5629 - 5636.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Sawitzki, B. Kieselbach, M. Fisser, C. Meisel, K. Vogt, M. Gaestel, M. Lehmann, K. Risch, G. Grutz, and H.-D. Volk
IFN-{gamma} Regulation in Anti-CD4 Antibody-Induced T Cell Unresponsiveness
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Kerry, J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen, P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger
Interplay between TCR Affinity and Necessity of Coreceptor Ligation: High-Affinity Peptide-MHC/TCR Interaction Overcomes Lack of CD8 Engagement
J. Immunol., November 1, 2003; 171(9): 4493 - 4503.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. L. Tamma and R. F. Coico
IgD-receptor (IgD-R) cross-linking partially protects murine T cells from dexamethasone-induced apoptosis
J. Leukoc. Biol., June 1, 2003; 73(6): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. L. Tamma, V. S. Kalyanaraman, S. Pahwa, P. Dominguez, and R. R. Modesto
The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells
J. Leukoc. Biol., May 1, 2003; 73(5): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Harding, P. Lipp, and D. R. Alexander
A Therapeutic CD4 Monoclonal Antibody Inhibits TCR-{zeta} Chain Phosphorylation, {zeta}-Associated Protein of 70-kDa Tyr319 Phosphorylation, and TCR Internalization in Primary Human T Cells
J. Immunol., July 1, 2002; 169(1): 230 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Campbell, T. Komata, and A. Kelso
CD4 Ligation Promotes the IL-4-Independent Development of IL-4-Producing Clones from Naive CD4+ T Cells
J. Immunol., November 15, 2001; 167(10): 5610 - 5619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Li, M. Crowley, A. Nguyen, and D. Lo
Ability of a Nondepleting Anti-CD4 Antibody to Inhibit Th2 Responses and Allergic Lung Inflammation Is Independent of Coreceptor Function
J. Immunol., December 15, 1999; 163(12): 6557 - 6566.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.